History of pancreatic neuroendocrine tumor with known liver metastases. ABDOMEN:LIVER, BILIARY TRACT: There are multiple T2 bright lesions within the liver having early arterial enhancement and a predominantly peripheral distribution with washout compatible with metastases. The largest lesion is in segment 7 and measures 2.4 x 2.3 cm (series 17 image 8). There are additional lesions in segments 6 and 5. The second largest lesion is in segment 6 and measures 2.2 x 2.1 cm (series 17 image 18).The background liver parenchyma demonstrates loss of signal on out of phase images compatible with hepatic steatosis. Cholelithiasis. No intrahepatic or extrahepatic biliary ductal dilatation.SPLEEN: No significant abnormality noted.PANCREAS: In the head of the pancreas there is a heterogeneously enhancing 2.2 x 1.5 cm mass (series 9 image 60). The enhancement has a predominantly peripheral distribution. There is marked atrophy of the pancreatic body and tail. There is mild prominence of the main pancreatic ducts distal to the mass measuring 4 mm in diameter.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Horseshoe kidney with fusion of the inferior poles. No focal lesion. No hydronephrosis. Note is made of multiple peripelvic cysts.RETROPERITONEUM, LYMPH NODES: No upper abdominal lymphadenopathy.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: Dependent soft tissue edema in the posterior soft tissues. Focus of increased T2 and T1 signal in the T12 vertebral body without enhancement compatible with an intraosseous hemangioma.OTHER: No significant abnormality noted.
Pancreatic head mass with multiple metastases in the right lobe of the liver as described compatible with patient's known metastatic tumor as above.